申请人:TAKEDA PHARMACEUTICAL COMPANY LIMITED
公开号:US10112956B2
公开(公告)日:2018-10-30
An object of the present invention is to provide a compound having a superior CH24H inhibitory action, which is useful as an agent for the prophylaxis or treatment of epilepsy, neurodegenerative disease and the like. The present invention relates to a compound represented by the formula:
wherein each symbol is as defined in the specification, or a salt thereof.
本发明的目的是提供一种具有优异的 CH24H 抑制作用的化合物,该化合物可用作预防或治疗癫痫、神经退行性疾病等的药物。本发明涉及一种由式表示的化合物:
其中各符号如说明书中所定义,或其盐。